Why the study?
Are there significant differences between three common whole blood point-of-care platelet function analyzers for measuring in vitro P2Y12 induced platelet inhibition?
Are there significant differences between three common whole blood point-of-care platelet function analyzers for measuring in vitro P2Y12 induced platelet inhibition?
There are significant differences between common whole blood point-of-care platelet function analyzers, highlighting the need to investigate their clinical impact.
Answers are grounded in this paper and cite their sources.
Significant differences between point-of-care analyzers may confound P2Y12 inhibition assessment; leaves open comparative outcome validation.
. Significant differences were found between whole blood point-of-care platelet function analyzers and the clinical impact of these differences needs to be further investigated.
No takes yet. Share an insight, caveat, or question.
Dias et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: